News

The life sciences industry never stands still. Drug approvals, clinical trial results, major acquisitions, and regulatory shifts can reshape the competitive landscape overnight. This category brings together the breaking stories and developing news from across the biotech, pharma, and healthcare sectors, separate from the deeper analysis and explainers found on our specialist category pages.

From FDA and EMA regulatory decisions to biotech and pharma company announcements, our newsroom reports on the events driving the industry forward as they happen. Topics span GLP-1 receptor agonists and obesity drug development, CRISPR and gene editing breakthroughs, CAR-T cell therapy, antibody-drug conjugates, radiopharmaceuticals, biosimilar approvals, precision medicine, and AI in drug discovery across oncology, rare diseases, autoimmune disorders, neuroscience, cardiovascular disease, and infectious disease.

Biotech IPOs, biopharma M&A deals, patent cliff developments, blockbuster drug patent expiries, pipeline updates, and strategic partnerships are tracked on the commercial side. Press releases published directly from biotech and pharmaceutical companies sit alongside editorial coverage.

Speed matters, but so does accuracy. Every story is grounded in peer-reviewed research, clinical trial data, regulatory filings, company disclosures, medical conference presentations, and expert commentary. Pharmaceutical industry news and medical research news are delivered so that healthcare professionals, pharmaceutical executives, clinical researchers, investors, and policy professionals get the full picture without delay.

Explore the latest news articles on this page. For the full picture across all categories, bookmark our home page at lifesciencedaily.news 

Don’t wait for the media to pick up your story. Be the media.